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Abstract
Background: We investigated the molecular mechanism of ß-lactam resistance in extended-spectrum ß-lactamase
(ESBL)-producing Enterobacterial strains isolated in neonatal units of different hospitals in Anatnanarivo,
Madagascar.
Methods: Bacteria were identified by standard biochemical methods, disc diffusion antibiograms and Etest.
Resistance genes were sought by PCR. Strains were characterized by Rep-PCR (Diversilab), plasmid analysis and
rep-typing.
Results: From April 2012 to March 2013, 29 ESBL-producing E. cloacae and 15 K. pneumoniae were isolated from
blood culture (n = 32) or gastric samples (n = 12) performed at day 0 or 2 from 39/303 newborns suspected of early
neonatal infection. These infants were treated with expanded spectrum cephalosporins, due to lack of
carbapenems, leading to a high mortality rate (45 %). Isolates recovered were all, but 4, multidrug resistant,
particularly to fluoroquinolones (FQ) except for 21 E. cloacae isolates. Isolates produced TEM-1 and CTX-M-15
ß-lactamases and their genes were located on several self-transferable plasmids of variable sizes sizes that could not
be linked to a major plasmid incompatibility group. E. cloacae isolates belonged to 6 Rep-types among which two
counted for 11 isolates each. The FQ resistant E. cloacae isolates belonged to one clone, whereas the FQ
susceptible E. cloacae isolates belonged to four clones. The K. pneumoniae isolates belonged to 9 Rep-types among
which one included five isolates.
Conclusion: This study is the first molecular characterization of ESBL-producing isolates from neonatology units in
Madagascar, a country with limited epidemiological data. It revealed an important multi-clonal dissemination of
CTX-M-15-producing isolates reflecting both the high community carriage and the very early nosocomial
contamination of the neonates.
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Background
Extended-spectrum β-lactamase (ESBL)-producing En-
terobacteriaceae represent a major worldwide threat
among drug-resistant bacteria in both hospital and
community settings [1]. They are mostly associated with
urinary tract infections, but may also cause significant
bloodstream-associated infections [1]. ESBLs are often
located on large plasmids that also harbor resistant
genes to other antimicrobial classes resulting in
multidrug-resistant isolates [1, 2]. Plasmid-encoded
ESBLs of the CTX-M-type are reported increasingly
worldwide in Gram-negative rods and account now for
most of the ESBLs found in Enterobacteriaceae [1, 3–5].
CTX-Ms form a rapidly growing family that comprises
currently up to 154 variants that are divided into five
groups according to amino-acid sequence identity
(CTX-M-1, −2, −8, −9 and −25 groups) with CTX-M-15
being the most prevalent in most countries [3–5].
BlaCTX-M-15 genes are often encoded on plasmids be-
longing to the incompatibility group IncF [2–4]. In the
upstream region of CTX-M genes an insertion sequence
element, ISEcp1, is commonly present and is likely re-
sponsible for the transposition process of the genes [6].
Over recent years, the importance of community-
acquired infections due to ESBL-producing isolates has
been increasingly demonstrated [3–5]. As a consequence,
fecal carriage of ESBL-producing isolates is now widely
studied in hospitals but also in healthy populations in the
community [5]. Surveys since 2000 have shown an alarm-
ing trend of associated resistance to other classes of anti-
microbial agents among ESBL-producing organisms
isolated from community sites [3, 4, 7].
ESBL-producing Enterobacteriae were first isolated in
Madagascar between 2005 and 2006 from community-
acquired urinary tract infections in 9.7 % of isolated En-
terobacteriaceae [8]. More recently, 21.3 % of clinical
isolates from patients in surgery and intensive care units
and 21.2 % of intestinal carriage isolates from children
hospitalized in a pediatric department of a large teaching
hospital were ESBL-producers [9, 10]. The prevalence of
carriage of ESBL in the community of Antananarivo was
estimated at 10 % in healthy people in 2011 [11]. The
most frequenly involved bacteria being Escherichia coli,
Klebsiella pneumoniae and Enterobacter cloacae. More
recently, Rasamiravaka et al. reported in 2015, a rate
12 % of ESBL- producing Enterobacteriacae in urine
samples [12]. The same year, Chereau et al., studying the
fecal carriage in pregnant women, reported a rate of
18.5 % of ESBL-producing Enterobacteriacae [13].
Infections are a major contributor to newborn deaths
in developing countries and are responsible for an esti-
mated 35 % of all neonatal deaths [14]. In resource-poor
countries, sepsis due to resistant Gram-negative bacilli is
an emerging problem and the currently recommended
first-line (penicillin/ampicillin plus gentamicin) or
second-line antibiotics (a third-generation cephalo-
sporin) do not provide adequate cover. Laboratory tests
are often not available and the diagnosis of neonatal
infections is based only on clinical signs leading to an
antimicrobial treatment often not adapted to the local
epidemiology. For this reason, we decided to conduct a
study in Madagascar to identify the epidemiology of bac-
terial early neonatal infections. This study allowed us to
show a predominance of Enterobacteriaceae and espe-
cially of ESBL-producing E.cloacae and K. pneumoniae.
None of the Escherichia coli strains isolated here were
ESBL-producers. Therefore, the present work focused on
the molecular mechanism of ß-lactam resistance in E.
cloacae and K. pneumoniae isolates identified in these
neonatal units of two different hospital at Antananarivo,
Madagascar.
Methods
Study design
During April 2012 and March 2013, newborns from the
two hospitals of Antananarivo with a suspected neonatal
infection determined based on a clinical score according
to the International and French consensus guidelines
(fever (>37°8C) or hypothermia (<35 °C), tachycardia or
bradycardia, arterial hypotension, poor perfusion, re-
spiratory distress, apnea, seizure, floppy infant, bulging
fontanel, irritability, lethargy, purpura were included [15,
16]. The French guidelines for materno-fetal infections
were used to categorize the clinical situations, as proved
infection when the blood culture was positive, probable
infection when the gastric fluid sample was positive with
a pathogen bacteria and a positive C-reactive protein
(CRP) [15].
Bacterial strains, antimicrobial agents and susceptibility
testing
Bacterial identification was performed using the API 20E
system (bioMérieux, Marcy-l’Etoile, France). Antibio-
grams for 32 antibiotics (amoxicillin, amoxicillin/clavula-
nic acid, aztreonam, ceftazidime, cefalotine, cefmandole,
cefotaxime, cefepime, cefoxitine, imipenem, meropenem,
Moxalactam, pipéracilline, ticarcilline, ticarcilline/acide
clavulanique, piperacilline/tazobactam, fosfomycine, colis-
tine, rifampicine, cotrimxazole, ciprofloxacine, pefloxacine;
norfloxacine, nalidixic acid, tetracycline, tigecycline,
chloramphenicol, kanamycine, amikacine, netilmicine,
tobramycine, gentamicine) were determined by the disc
diffusion method on Mueller-Hinton agar (BioRad,
Marnes-La-Coquette, France) and the susceptibility break-
points were determined and interpreted as recommended
by the Clinical and Laboratory Standards Institute [17].
All plates were incubated at 37 °C for 18 h. Minimum
inhibitory concentrations (MICs) of given ß-lactams were
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determined using the Etest technique (bioMérieux, Marcy
l’Etoile, France) for the following β-lactam antibiotics:
amoxicillin ± clavulanic acid, cefoxitin, cefotaxime, ceftazi-
dime, aztreonam, cefepime and imipenem. Confirmation
of ESBL producers was performed by double disc synergy
testing between ticarcillin/clavulanate and aztreonam and/
or ceftazidime and/or cefepime [18].
Nucleic acid extractions, PCR and DNA sequencing
Whole-cell DNAs were extracted using QIAamp DNA
Mini Kit (Qiagen, Les Ulis, France). The blaCTX-M,
blaSHV, blaTEM, minor ESBL and quinolone resistant
qnrA, B and S genes were searched for by PCR and sub-
sequently characterized by Sanger sequencing. PCR
experiments were performed on an ABI 2700 thermocy-
cler (Applied Biosystems, Les Ulis, France) using
laboratory-designed primers [19]. Both strands of the
PCR products, were sequenced using laboratory-
designed primers with an automated sequencer (ABI
PRISM 3100; Applied Biosystems). The nucleotide and
the deduced protein sequences were analyzed using soft-
ware available at the National Center of Biotechnology
Information website (http://www.ncbi.nlm.nih.gov).
Plasmid content, mating out and electroporation
experiments
Direct transfer of resistance into azide-resistant E. coli
J53 was attempted by liquid and solid mating-out assays
at 30 and 37 °C [19]. Transconjugant selection was
performed on trypticase soy agar plates (bioMérieux)
containing ciprofloxacin (3 mg/ml) and either ceftazi-
dime (10 mg/ml) or ticarcillin (150 mg/ml).
Plasmids were introduced by electroporation into E.
coli TOP10 using a Gene Pulser II (BioRad). Natural
plasmids were extracted using Kieser extraction method
and subsequently analyzed by electrophoresis on a 0.7 %
agarose gel [20].
Replicon typing
PCR-based replicon typing (PBRT) of the main plasmid
incompatibility groups reported in Enterobacteriaceae
was performed as described [21] using the respective
PBRT controls. The obtained amplicons were sequenced
to confirm their identity. Genetic structures surrounding
the blaCTX-M gene were determined by PCR using
primers specific of the known genetic environment of
group 1 CTX-M variants [19].
Fingerprinting analysis
Genomic relatedness of the K. pneumoniae and E. clo-
acae isolates was investigated by semi-automated rep-
PCR typing (Diversilab®, bioMérieux) as recommended
by the manufacturer. Isolates were considered belonging
to a same clone if they shared at least 95 % similarity.
Results
Patients
Between April 1st, 2012 and March 31st 2013, 8500
newborn (NB) were born in the two hospitals (Befeleta-
nana and Soavinandriana). Among them, 303 NB (3.6 %)
had clinical signs of maternal infections and were in-
cluded in the study, 164 were from Befelatanana (B) and
139 from Soavinandriana (S). The mean gestational age
of the NB was 38 ± 3.5 weeks gestationnal age (WA)
comprised between 24 and 43 (Table 1). Out of the 303
NB, 60 (19.5 %) were born before 38 weeks, among
which 20 were born before 32 weeks and 40 between 32
and 36 weeks. The sex ratio of the NB was 172 (56.8 %)
males and 131 (43.2 %) females. Gastric fluid was sam-
pled from 282 NB, blood culture from 254 NB, and CRP
determination from 272 NB. Pregnancy monitoring
results are indicated in Table 1.
Bacterial epidemiology
During the study period, 168/254 (66.1 %) blood cul-
tures, 60/282 (21.3 %) gastric fluids, and 102/272
(37.5 %) CRP (cutoff > 6 mg/L) were positive. For 58 NB
the CRP was >20 mg/L. Results obtained in each of the
two hospitals are summarized in Table 1.
Among the 168 positive blood cultures, 92 were positive
with Staphylococcus coagulase negative or Corynebacteriae
and were therefore considered as contaminated. Finally,
76 were positives with 99 bacterial isolates and therefore
corresponded to a proven infection. Enterobacteriaceae
(51/99, 51.5 %) among which Enterobacter cloacae 28/51
(54.9 %), Klebsiella pneumoniae 14/51 (27.5 %), Escheri-
chia coli 7/51 (13.7 %) and Proteus mirabilis 2/51 (3.9 %)
were the most predominant isolates (Table 1). Group B
Streptococcus, Acinetobacter baumannii and Enterococcus
sp. represented respectively 9, 8 and 14 % of the isolates.
Among these 76 positive blood culture, 13 were
positive with two bacteria: Enterobacter cloacae with
Klebsiella pneumoniae (five cases), E. cloacae with En-
terococcus faecalis (one case), Acinetobacter baumanii
was associated with E. faecalis or Streptococcus sp or
Proteus mirabilis (three cases), E. faecalis was associated
with E. coli (three cases), and Staphylococcus aureus
(one case).
Twenty four NB were considered as probably infected
since they had a positive gastric fluid culture, a negative
blood culture and an elevated CRP according to the
French guidelines. Bacteria involved were mostly Gram-
negative bacteria (12 E. coli, 6 E. cloacae, one K. pneu-
moniae, and four group B Streptococcus and one S.
aureus). All other NB were considered as only colonized.
In all, 47/303 (15.5 %) NB died. The mortality rate was
41/164 (25 %) at B and 6/139 (4.3 % at S). Among these,
25 died of neonatal infection (20 with positive blood cul-
ture and five with positive gastric fluid and elevated
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Table 1
Total n (%) Befelatanana n (%) Soavinandriana n (%) p-value
Neonates
Number 303 164 139
Sex
Male
Female 172 (56.8) 90 (54.9) 82 (59.0)
131 (43.2) 74 (45.1) 57 (41.0) 0.54
Sex-ratio 1.3 1.2 1.4 0.54
Gestational age (weeks) [mean] 38 [24–43] 38 [24–43] 38 [26–42] 0.25
Birth weight (g)
[mean, 95%CI]
2663
[2576–2750]
2559
[2441–2677]
2785
[2658–2912]
0.01
Antimicrobial treatment 154 (50.8) 120 (73.2) 34 (24.5) <0.01
Death 47 (15.5) 41 (25) 6 (4.3) <0.01
Gastric samples
Positive Gastric samples
True Positives (contamination excluded)
Bacteria
Escherichia coli
ESBLa-producer
Enterobacter cloacae
ESBL-producer
Klebsiella pneumoniae
ESBL-producer
Group B Streptococcus
Other organismsb
282 (93.1) 143 (87.2) 139 (100)
60 (21.3) 34 (23.8) 26 (18.7) <0.01
72 39 33
32 (44.4)
0
15 (38.5)
0
17 (51.5)
0
0.68
11 (15.3)
7
7 (17.9)
5
4 (12.1)
2
6 (8.3)
5
4 (10.2)
3
2 (6.1)
2
4 (5.5) 2 (5.1) 2 (6)
19 (26.3) 11 (28.2) 8 (24.2)
Blood cultures
Positive blood cultures
254 (83.8) 145 (88.4) 109 (78.4)
True Positives (contamination excluded)
Bacteria
76 (29.9) 62 (42.8) 14 (12.8) <0.01
99 79 20
Escherichia coli
ESBL-producer
Enterobacter cloacae
ESBL-producer
Klebsiella pneumonia
ESBL-producer
Acinetobacter baumannii
Group B Streptococcus
Enterococcus sp
Other organismsc
7 (7.1)
0
4 (5.14)
0
3 (15)
0
28 (28.3)
28
27 (34.2)
27
1 (5)
1
<0.01
14 (14.1)
11
13 (16.4)
10
1 (5)
1
8 (8.1) 6 (7.6) 2 (10)
9 (9) 5 (6.3) 4 (20)
14 (14.1) 12 (15.1) 2 (10)
19 (19.1) 12 (19.2) 7 (35)
Mothers
Antibiotic before delivery 36 (11.9) 5 (3) 31 (22.3) <0.01
Pregnancy monitoring
Hospital
Health center
General practitioner
Mid-wife
No follow up
101 (33.3) 10 (6.1) 91 (65.5) <0.01
97 (32) 69 (42.1) 28 (20.1)
35 (11.6) 25 (15.2) 10 (7.2) 0.33
38 (12.5) 33 (20.1) 5 (3.6)
22 (7.3) 20 (12.2) 2 (1.4) <0.01
Intrapartum antibiotic 77 (25.4) 11 (6.7) 66 (47.5) <0.01
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CRP). Among these 25, 24 were born at B of which eight
had a positive blood culture with an ESBL-producing E.
cloacae, four with an ESBL-producing K. pneumoniae
and two with the both. Others had a positive blood
culture with A. baumannii (n = 1), Haemophilus
influenzae (n = 2), E. coli (n = 2) and Streptococcus
anginosus (n = 1).
Bacterial isolates and antibiotic susceptibility
Bacterial isolates and results are summarized in Table 1.
Gram negative were the most prevalent bacteria (115/171
isolated bacteria). Among these, 108 were identified as E.
coli (n = 39), K. pneumoniae (n = 20), E. cloacae (n = 39),
or Acinetobacter baumannii (n = 10). Looking at the anti-
microbial susceptibility, 35/39 E. cloacae and 16/20K.
pneumoniae were ESBL-producers as revealed by a typical
synergy image between clavulanic acid and expanded-
spectrum cephalosporins and were selected for further
analysis. Their distribution by hospitals is described
Table 1. None of the E. coli isolates were ESBL-producers.
Antibiograms revealed that all ESBL-producing
isolates were multidrug-resistant and most of them were
resistant to first line antibiotics (ampicillin, cefotaxime
or gentamicin) used to treat neonatal infections. In
addition, high rates of resistance to gentamicin (88.9 %)
tobramycin (81.5 %), ciprofloxacin (35 %) and to
Fig. 1 Rep-PCR results showing genetic relatedness between the 29 ESBL-producing E. cloacae (a) and the 15 ESBL-producing K. pneumoniae (b) isolates
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trimethoprim-sulfamethoxazole (87 %), were observed
They were susceptible to imipenem while K. pneumoniae
isolates were also susceptible to cefoxitin. Resistance to
cefoxitin in all E. cloacae isolates was due to the
inducible production of AmpC β-lactamase from a
chromosomal gene. Among ESBL-producers, 16/17 K.
pneumoniae and 10/39 E. cloacae isolated from blood or
gastric samples were resistant to fluoroquinolones (FQR).
The finding of multidrug resistance among ESBL-
producing isolates is of great clinical relevance due to the
limited therapeutic options and the high risk of treatment
failure in patients infected with these strains.
Molecular epidemiology of ESBL-producers
Among the 35 ESBL- producing E. cloacae 29 were fur-
ther studied, 21 were isolated from blood culture (20
from B and one from S) and eight were isolated from
gastric fluid samples. Eight out of the 29 were resistant
to fluoroquinolones. Rep-PCR analyses (Fig. 1) revealed
that E. cloacae isolates belonged to 6 Rep-PCR-types
among which two counted for 11 isolates each. Clone 1
(P1) included 11 strains (one from gastric fluid and ten
from blood culture) either resistant to fluoroquinolones
(n = 7) or susceptible (n = 4) and was present all along
the study period (Fig. 2). Conversely, clone 6 (P6) in-
cluded also 11 strains (six from blood culture and five
from gastric fluis sample), all resitant to fluoroquino-
lones and was present for a shorter period of 6 months.
One NB exhibited the same strain in blood and gastric
fluid and died.
The seven remaining strains were divided into four
different clones. Clones 2 (P2), isolated at B was repre-
sented each by only one strain from a gastric fluid.
Clone 5 (P5) was isolated only at S in gastric fluid and
blood from two different NB. In April 2012, three clones
were present at the same time at B (Fig. 2).
Among the 16 ESBL-producing K. pneumonia, 15
were studied, 11 were isolated from blood culture (ten
from B and one from S) and four were isolated from
gastric fluid samples. K. pneumoniae isolates were of
more diverse origin (Fig. 1): they belonged to 9 Rep-
PCR-types among 1 (P5) included five isolates sharing
more than 95 % similarity. Two other clones (P1 and P3)
were represented each by two isolates and the six
remaining clones included only one strain (Fig. 1). Clone
1 (P1) included two strains and was present at B hospital
Fig. 2 Isolation of the different clones of ESBL-producing E. cloacae (n = 6) and K. pneumoniae (n = 9) over the study period. a all strains were isolated
at B and were susceptible to fluroquinolones; b all strains were isolated at S, one susceptible and one resistant to fluroquinolones respectively; c all
strains were isolated at B, one susceptible and one resistant to fluroquinolones respectively; d all strains were isolated at B, five susceptible and six
resistant to fluroquinolones respectively; e all strains were isolated at S and resistant to fluroquinolones; f all strains were isolated at B and resistant
to fluroquinolones
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at the beginning and at the end of the study. Clone 3
(P3) (including two strains, one from blood culture and
one from fluid gastric sample from the same NB) was
present only in S hospital. The clone 5 (P5) was present
at Befelatanana hospital in May to October. Other iso-
lates were isolated from gastric samples, belonged to
three or four different profiles and were all isolated at B.
Interestingly, four blood cultures were positive with
both K. pneumoniae and E. cloacae isolates. In two
cases, the Rep-PCR profiles were different for both bac-
teria. In two other cases, the blood cultures isolated
from two different NB born two days apart exhibited the
same profile for E. cloacae (P1) but different profiles for
K. pneumoniae (P4 and P9).
Molecular analysis
ESBL producing isolates harboured blaCTX-M and blaTEM
genes as revealed by PCR. Sequencing of the PCR prod-
ucts revealed that blaCTX-M-15 and blaTEM-1 genes were
present in all isolates. PCR-sequencing of the genetic en-
vironment of blaCTX-M gene revealed the presence of
ISEcp1 insertion sequence located upstream of all
blaCTX-M-15 gene. The ESBL-producing isolates con-
tained several plasmids of different sizes, ranging from
less than 5 kb to more than 150 kb (Fig. 3). Both resist-
ance genes were carried on several self-transferable plas-
mids of variable sizes. For E. cloacae isolates, clone P1
exhibited only one plasmid whereas clone P6 exhibited
at least five plasmids of different size. Transformants
into E. coli DH10B could be obtained with most of the
isolates. The E. coli transformants had a ß-lactam
resistance pattern that correspond to the expression of
an ESBL-like gene. Transformants obtained with E. clo-
acae P1 and K. pneumoniae P5 were also resistant to
gentamicin, tobramycin, tetracycline, cotrimoxazole and
chloramphenicol. Transformants obtained with E. clo-
acae P6 harbored the same profile but were susceptible
to tetracycline and cotrimoxazole. The blaCTX-M-15 gene
carrying plasmid could also be transferred by conjuga-
tion to E. coli J53 for all the isolates. PCR-based replicon
typing of the main plasmid incompatibility groups re-
ported in Enterobacteriaceae was not able to identify the
inc group of the plasmids carrying blaCTX-M-15 gene.
The quinolones resistant isolates were tested negative
for qnrA, B and S.
Discussion
Between April 2012 to March 2013, 35 E. cloacae and
16 K. pneumoniae isolates producing an ESBL were iso-
lated from blood cultures (n = 39) or gastric fluid sam-
ples (n = 12) performed at day 0 or 1 from 39/165
newborns suspected of early-onset neonatal infection.
These NB were treated with ceftriaxone, due to lack of
carbapenems, and resulted in a high mortality rate. Mo-
lecular studies could be performed on 29 ESBL-
producing E. cloacae and 15 ESBL-producing K. pneu-
moniae. All strains exhibited blaCTX-M-15 ESBL gene.
The CTXM-15 ESBL is considered to be the most preva-
lent ESBL worldwide [1, 3, 4]. Our findings confirm the
predominance of blaCTX-M-15 among ESBL producing
isolates. Previously in 2009, the blaCTX-M-15 gene has
already been reported to be the most prevalent ESBL in
A B
Fig. 3 Plasmid analysis by Kieser method and corresponding clones obtained by Rep-PCR (P): (a) 15 ESBL-producing E. cloacae, 5/6 clones
are represented with the two main ones P1 and P6; (b) 15 ESBL-producing K. pneumoniae isolates, 9/9 clones are represented. M: E. coli
50192, reference strain harboring four plasmids (molecular size plasmid marker). “C” indicated the chromosomal DNA band
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Madagascar, as it was detected in 75.5 % of Enterobacte-
riaceae isolated from feces [11]. These results were con-
firmed in 2015 showing an increase in the prevalence of
colonization by ESBL-producing Enterobacteriaceae
(18 %, among which 68 % carried the blaCTX-M-15 gene),
consistent with the worldwide increase of ESBL-
producing Enterobacteriaceae carriage in the community
[13]. This predominance is is highlighted by a study
involving nine Asian countries reported that blaCTX-M-15
gene was highly prevalent among ESBL-producing K.
pneumoniae isolates (60 %, 55/92) [22].
CTX-M genes may disseminate through clonal expan-
sion or horizontal gene transfer [3, 4]. In our study,
ISEcp1 was found upstream from blaCTX-M-15 at variable
distances, as was previously described [7, 23]. ISEcp1
was found to be in the vicinity of many blaCTX-M genes
(including blaCTX-M-15) and was reported to be respon-
sible of the expression of downstream located genes [6].
The plasmids carrying blaCTX-M-15 were assigned to the
IncFII, IncFIA or IncHI2 incompatibility group replicons
[2]. Association of the blaCTX-M-15 gene with IncF plas-
mids carrying the FII replicon in association with the
FIA or FIB replicon has been reported previously for iso-
lates in Canada, France, Spain, Tunisia, and the United
Kingdom [2–4, 24]. The IncHI2 plasmid, frequently
associated with blaCTX-M-2 or blaCTX-M-9, was first iden-
tified in Serratia marcescens [2], but rarely reported in
association with blaCTX-M-15. In our study blaCTX-M-15
gene could not be linked to a major plasmid incompati-
bility group by PCR.
Our study presents some limitations, especially the
lack of vaginal samples of the mother prior birth, which
would have allowed to distinguish nosocomial and a
maternal transmission. The hypothesis of nosocomial
infection is more likely with regard E. cloacae as two
Rep-PCR-types represented each 11 identical isolates
from the same hospital, one isolated throughout the
study (EC-P1) and another only the first 6 months (EC-
P6). The clone EC-P4, including three isolates, was
present only in April. Conversely, the K. pneumoniae are
of much more diverse origin since they belonged to 9
Rep-PCR-types among two included only two isolates
and the six other clones only one strain. In two cases,
the E. cloacae strains isolated both from the gastric sam-
ple and blood sample belonged to the same clone (EC-
P5 at S hospital and EC-P6 at B hospital).
A community origin and therefore a mother-to-child
transmission can then be discussed in this case. This
hypothesis was evocated by Cherau et al. who investi-
gated the ESBL-PE rectal colonization among pregnant
women at delivery in the community in Madagascar and
estimated a prevalence ranging from 14.5 to 22.6 %
according to the place [13]. Conversely, the nosocomial
hypothesis is supported by the data of a previous study,
reporting a clonal outbreak of K. pneumoniae harboring
blaCTX-M-15 and blaSHV-2 genes described in the neonatal
units of two hospitals in Antananarivo and highlighting
the role of contaminated aspiration tubes [25]. The pre-
cocity of neonatal infections due to E. cloacae and K.
pneumoniae occurring between D0 and D1 in this study
study does not allow to discriminate between the two
hypothesis. It is likely that the two causes of infection
have coexisted: the nosocomial hypotheses is more
plausible for E. clocae (two major clones) and commu-
nity hypothesis for K. pneumoniae. Interestingly, no
relationship between the two hospitals has been demon-
strated. This is confirmed by the fact that the strains of
E. cloacae were isolated mainly to the hospital B, except
two belonging to a different clone. Interestingly, B hos-
pital supports more deliveries per year (about 7000 vs
1500) with a population of a lower socioeconomic level.
Our study further underscores that in developing
countries, neonatal infections are mainly due to Gram-
negative bacteria and especially K. pneumoniae (respect-
ively 57.4 and 26.4 %) as reported by Zaidi et al. [26].
We found also the same percentage of A. baumannii
(8 %), Group B Streptococcus (8 %) and a lower percent-
age of E. coli (7 %) similarly to previous studies [26, 27].
Neonates are exposed to external risks factors, particu-
larly deficient hygiene that put them at high risk of neo-
natal infection and if neonatal culture confirmed sepsis
rates is of 1–3 per 1000 live births reported from indus-
trialized countries [28], this rate can reached 37 per
1000 live births in developing countries [29, 30]. Poor
quality of care in developing countries are a major
source of neonatal infections for hospital-born infants.
Lack of infection-control procedures, inadequate
sterilization of multiuse instruments, understaffing and
overcrowded nurseries are responsible for nosocomial
infections in most hospitals in developing countries and
promotes neonatal infections due to environmental
pathogens as reflected in this study by the positivity of
the gastric samples cultures with E. cloacae and K. pneu-
moniae [31]. A supplementary burden being the high
antimicrobial drug resistance rates due to a combination
of several factors, including irrational antimicrobial drug
use [5]. In addition, imipenem was not marketed in
Madagascar at the time of the study explaining, in part,
this elevated mortality.
Conclusion
This study confirmed the global emergence of blaCTX-M-15
genes from a country with limited epidemiological data. In
addition, this is the first molecular characterization of
ESBL-producing isolates from Neonatology ward in
Madagascar. We confirmed a high prevalence and the
multi-clonal dissemination of blaCTX-M-15 genes among
these isolates thus reflecting both high community
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carriage and a very early nosocomial contamination of the
neonates. These findings underline the need for a rational
use of antibiotic and for preventive hygiene strategies,
which can reduce the burden of neonatal infections in
these countries.
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